BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29463235)

  • 1. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.
    Bosco C; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
    BMC Cancer; 2018 Feb; 18(1):205. PubMed ID: 29463235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
    Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
    Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
    Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study.
    Van Hemelrijck M; Walldius G; Jungner I; Hammar N; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L
    Cancer Causes Control; 2011 Jul; 22(7):1011-9. PubMed ID: 21562751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort.
    Shackshaft L; Van Hemelrijck M; Garmo H; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
    Breast Cancer Res; 2017 Mar; 19(1):22. PubMed ID: 28264697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study.
    Arthur R; Møller H; Garmo H; Häggström C; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
    Cancer Causes Control; 2019 Feb; 30(2):195-206. PubMed ID: 30421156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study.
    Van Hemelrijck M; Jassem W; Walldius G; Fentiman IS; Hammar N; Lambe M; Garmo H; Jungner I; Holmberg L
    Eur J Cancer; 2011 Sep; 47(13):2033-41. PubMed ID: 21486691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
    Kunutsor SK; Laukkanen JA
    Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories.
    Arthur R; Møller H; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Hemelrijck MV
    Cancer Med; 2016 Jun; 5(6):1307-18. PubMed ID: 26923095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cancers before and after prostate cancer diagnosis.
    Van Hemelrijck M; Drevin L; Holmberg L; Garmo H; Adolfsson J; Stattin P
    Cancer; 2012 Dec; 118(24):6207-16. PubMed ID: 22674346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    Abhyankar N; Hoskins KF; Abern MR; Calip GS
    BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.
    Essén A; Santaolalla A; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
    Cancer Causes Control; 2019 Jun; 30(6):603-615. PubMed ID: 31020446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
    Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
    Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
    Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
    Eur Urol; 2012 Apr; 61(4):690-700. PubMed ID: 21945719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lipid levels and prostate cancer risk; a cohort study.
    Kok DE; van Roermund JG; Aben KK; den Heijer M; Swinkels DW; Kampman E; Kiemeney LA
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):340-5. PubMed ID: 21727905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.
    Zitt E; Pscheidt C; Concin H; Kramar R; Lhotta K; Nagel G
    PLoS One; 2016; 11(8):e0161376. PubMed ID: 27537361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
    Melvin JC; Garmo H; Holmberg L; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
    BMC Cancer; 2017 Apr; 17(1):246. PubMed ID: 28376727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease.
    Aksakal E; Tanboga IH; Kurt M; Kaygın MA; Kaya A; Isik T; Ekinci M; Sevimli S; Acikel M
    Atherosclerosis; 2012 Apr; 221(2):596-601. PubMed ID: 22369933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study.
    Van Hemelrijck M; Hermans R; Michaelsson K; Melvin J; Garmo H; Hammar N; Jungner I; Walldius G; Holmberg L
    Cancer Causes Control; 2012 Aug; 23(8):1349-58. PubMed ID: 22710746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.